Pacira Biosciences
PCRX
Market capitalization of Pacira Biosciences (PCRX)
Market cap: $1.18 Billion
As of April 2024 Pacira Biosciences has a market cap of $1.18 Billion. This makes Pacira Biosciences the world's 4872th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Pacira Biosciences from 2011 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $1.18 B | -24.28% |
| 2023 | $1.56 B | -11.56% |
| 2022 | $1.77 B | -33.9% |
| 2021 | $2.68 B | 3.1% |
| 2020 | $2.59 B | 36.94% |
| 2019 | $1.89 B | 7.05% |
| 2018 | $1.77 B | -4.24% |
| 2017 | $1.85 B | 53.3% |
| 2016 | $1.20 B | -57.3% |
| 2015 | $2.82 B | -11.72% |
| 2014 | $3.20 B | 65.75% |
| 2013 | $1.93 B | 239.3% |
| 2012 | $0.56 B | 282.42% |
| 2011 | $0.14 B |
End of Day market cap according to different sources
On Apr 24th, 2024 the market cap of Pacira Biosciences was reported to be:
$1.20 Billion
$1.20 Billion
$1.20 Billion
$1.20 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Zogenix ZGNX | $1.50 B | 26.45% | 🇺🇸 USA |
 Recro Pharma
REPH | $0.12 B | -89.61% | 🇺🇸 USA |
 Omeros Corporation OMER | $0.17 B | -85.05% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | $0.45 B | -61.32% | 🇺🇸 USA |
 Heron Therapeutics HRTX | $0.38 B | -67.69% | 🇺🇸 USA |
 Cara Therapeutics
CARA | $38.26 M | -96.77% | 🇺🇸 USA |